Can someone explain today's bump?

That sounds reasonable.

Very nice summary. Thanks for that.

I have so many on ignore here that I often go 80-100 posts that I don't see at all.

I have contacted the broker off-shore where you can short OTC stocks. But you have to put up $2.50 for every share you want to short. No one in the world would do that. Do the math. So I am sure there is no real shorting of this stock.

No. No shorting on any OTC stock. But I'm tired of debating this topic. This drop is simply a person with a lot of shares or a small group selling to cause more selling, and then they buy back cheap. Happens all the time. Common strategy.

And one other thing. I was here when the last CEO was in place. And Hakim is an order of magnitude better, regardless of his dealings with Micah. I know you did not touch this topic PS, but I thought I would put my thought here.

I agree. I'm at 500,000 shares at $.09. Not selling until about a dollar.

Are we really worth 2, 3, or 4 billion dollars? Now, or even in 1-2 years? I simply do not know.

We should go up this week. IMO, we break the 20 cent barrier.

RSPI is about ready to go.

Looks like another move up day. Time to settle in the 20s.

IMO, we close above 20 cents by end of week.

Highest pps in about 7 years.

Bingo!!

Do we move into the 20s today? I think so.

Some MMs just aren't open yet to show their current bids and asks.

Expecting large volume today and an uptick in pps. And, we are back to 12 MMs.

Gaps never concern me.

Looks like a gap up this am. Moving into long-awaited territory.

I love the way this is trading. We have a fun year coming up, IMO.

It is on the website.

https://respirerx.com/

Good. Because I need this at a dime.

All right. Let's light this candle this year!

I'm sure it depends on the drug.

How did you determine that market cap?

Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant

NORTHVALE, NJ / ACCESSWIRE / December 26, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today announced the US Food and Drug Administration's (FDA) acceptance for review of an Abbreviated New Drug Application (ANDA) on December 21, 2023, for an undisclosed generic drug product in a class of medications known as central nervous stimulants.IQVIA reported annual sales for the twelve months ending June 2023 of $5.1 billion for the brand and generic market for this product.

Dec 12, 2023

Elite Pharmaceuticals Announces First Product Shipment Of Generic Adderall XR® To Marketing Partner Prasco, LLC

NORTHVALE, NJ / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced the first shipment of generic Adderall XR® to its distribution and marketing partner Prasco, LLC ("Prasco"). Adderall XR® is an extended-release mixed salt of a single entity Amphetamine product (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate) with strengths of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg capsules (the "Products").

Prasco is, pursuant to the manufacturing and supply agreement dated April 5, 2023 ("Agreement") between the companies, a non-exclusive U.S. distributor of the Products. Prasco will market the Products under Burel Pharmaceutical's label, and Elite will manufacture the Products. Elite's product is co-owned with Mikah Pharma.

About Prasco, LLC
Prasco is a privately held healthcare company located in Mason, Ohio. Over 50 of the most innovative and trusted pharmaceutical companies have relied on Prasco to bring their products to the US generic marketplace. Prasco provides patients with high-quality products at affordable prices in over 60,000 US pharmacies. For more information, visit the company's website at www.prasco.com.

About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and distributes niche generic products. Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to third-party pharmaceutical marketing and distribution organizations. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.

The tweet told us it was wet weight.

I have been in dozens of OTC stocks over the past 20 years. Many were outright scams. But this one is a legit company with legit products, IMO. However, every OTC company struggles with the financial basics, no matter how legit they are.

Jeffrey has responded within a day to every email I ever sent him. No complaints here on that front.

PR about what?

Looking really good here.

IMO, we close above .16 by Friday and probably hit .17 at least once.

Yep, the RS killed me. But I remain optimistic. Fortunately, I have ELTP to save me.

This is trading well now, but I need it to get to a dollar to break even. LOL.

Wow, that is super significant.

I never understand the trading of this thing at all.

Don't see where you get a number that low, but I seriously doubt it.

So, do we finish in the green or red today? After yesterday's very positive CC, we should finish up, but who knows.

After hearing this CC, I have never been more confident in any stock I have owned in 20 years. We certainly will get to dollarland.